Skip to main content
OpenTrials

Clinical trial condition

Esophageal Neoplasms

Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.

1,231 public trials 309 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Neoplasms trial results

Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Innere Medizin II, LKH Feldkirch Feldkirch, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
View Trial Details
Completed

A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer

NCT01249352

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • Hospital Evangélico do Cachoeiro do Itapemirim Cachoeiro de Itapemirim, Espírito Santo, Brazil
  • Hospital Universitário de Brasília Brasília, Federal District, Brazil
  • Santa Casa de Misericórdia de BH Belo Horizonte, Minas Gerais, Brazil
  • Hospital Erasto Gaetner Curitiba, Paraná, Brazil
View all 19 locations
View Trial Details
Completed

PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

NCT04484636

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +28 more
Locations
  • KHNW Frankfurt Frankfurt am Main, Hesse, Germany
  • Hannover Medical School Hanover, Lower Saxony, Germany
  • Onkologische Schwerpunktpraxis Speyer Speyer, Rhineland-Palatinate, Germany
  • Elblandklinikum Riesa Ried, Saxony, Germany
View all 46 locations
View Trial Details
Completed

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

NCT02689284

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +11 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • Georgetown University-Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Medical Center Baltimore, Maryland, United States
View all 28 locations
View Trial Details
Completed

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +68 more
Locations
  • Clinical Site Fort Payne, Alabama, United States
  • Clinical Site Orange City, Florida, United States
  • Clinical Site Stuart, Florida, United States
  • Clinical Site Dublin, Georgia, United States
View Trial Details
Completed

Pre-Surgery If Needed for Oesophageal Cancer

NCT03937362

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • Shanghai Chest Hospital Shanghai, China
  • Queen Mary Hospital Hong Kong
  • Erasmus MC Cancer Institute Rotterdam, Netherlands
  • Chang Gung Memorial Hospital Linkou District, Taiwan
View Trial Details

Related conditions